RE:RE:RE:Great NewsNice to see this focus on growth and listening to both institutional investors/ retail on format and adding to board. Feels like the start of a natural growth cycle for this company. With the scientific advisory board building would be nice to see it updated on the website and more growth within BoD and management. Our peers like Sigilon or other Canadian biotech like Tril all have at least 3x Management/BoD/SAB ect//
. I do appreciate quality over quantity but it would be nice to work towards a certain critical mass reflective of a company with 400mil MC and multi billion potential.
Anyways rather than being negative about every move think of a positive feedback loop. This is the right direction that is likely reflective of growth to come and hopefully builds to a positive addition to the BoD and management. Negative feedback on a positive direction doesn't get us anywhere.